Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Clinical Trial

NCT02457143 | Completed

• 1 other identifier: 15-145
• Study Type: interventional
• Target: 5,270
• Locations: 1 country
• Sites: 1

Brief Summary

This randomized trial aims to understand how effective a reminder letter is compared to a reminder phone call in improving breast, cervical and colorectal cancer screening rates and reducing screening disparities.

Conditions

Early Detection of Cancer; Cancer; Socioeconomic Status

Keywords

recall; income-related disparities; cancer screening

Outcome Measures

Primary Outcomes (2)

• The proportion of patients in each arm who go on to receive at least one screening test for which they are due

  6 months

• The proportion of patients in each arm who are due for breast, cervical and colorectal cancer screening who go on to receive those respective screening tests (female patients may be represented in the outcome calculation of more than one cancer screening

  6 months

Study Arms (2)

Letter

EXPERIMENTAL

Patients will receive a reminder letter signed by their family physician which indicates which cancer screening tests they are overdue for and encourages them to book an appointment for screening.

Behavioral: Letter

Phone call

EXPERIMENTAL

Patients will receive a phone call from a member of the practice staff. The call will inform them about which cancer screening tests they are overdue for and will encourage them to book an appointment for screening.

Behavioral: Phone call

Interventions

Letter BEHAVIORAL

Letter

Phone call BEHAVIORAL

Phone call

Eligibility Criteria

• Age: 21 Years - 74 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• The trial will include patients who are rostered to the family practice as of March 31, 2015, are eligible and overdue for cervical, breast and/or colorectal cancer screening and are verified by their primary care physician as needing recall.

You may not qualify if:

• Patients will be excluded if their primary care physician noted they should not be recalled for screening or if the patient does not have both an address and a phone number on file.

Sponsors & Collaborators

• Unity Health Toronto: lead

Study Sites (1)

St. Michael's Hospital Academic Family Health Team

Toronto, Ontario, M5B1W8, Canada

Location

MeSH Terms

Conditions

Neoplasms

Interventions

College Fraternities and Sororities

Intervention Hierarchy (Ancestors)

Organizations; Health Care Economics and Organizations

Study Officials

• Aisha Lofters, MD PhD CCFP

  Unity Health Toronto

  PRINCIPAL INVESTIGATOR

• Tara Kiran, MD MSc CCFP

  Unity Health Toronto

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 27, 2015
• First Posted: May 29, 2015
• Study Start: July 1, 2015
• Primary Completion: July 1, 2016
• Study Completion: July 1, 2016
• Last Updated: October 17, 2016

Record last verified: 2016-10

Locations

CA (1)